Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 2, 2010, Pages 183-186

  Narkewicz, Michael R ^a   Rosenthal, Philip ^b   Schwarz, Kathleen B ^c   Drack, Arlene ^d   Margolis, Todd ^b   Repka, Michael X ^c  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

hepatitis C; interferon; retinopathy

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ARTICLE; BLINDNESS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EYE DISEASE; EYE EXAMINATION; EYE MOVEMENT; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCULAR BLINDNESS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA ISCHEMIA; SCHOOL CHILD; SLIT LAMP; TREATMENT DURATION; UVEITIS; VISUAL ACUITY; VISUAL DISORDER;

ADOLESCENT; ANTIVIRAL AGENTS; BLINDNESS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; ISCHEMIA; MALE; RETINAL DISEASES; UVEITIS;

GOSSYPIUM HIRSUTUM; HEPATITIS C VIRUS;

EID: 77955228534     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181b99cf0     Document Type: Article

References (23)

1. Szabo E, Lotz G, Paska C, et al. Viral hepatitis: new data on hepatitis C infection. Pathol Oncol Res 2003;9:215-221
2. Jhaveri R, Grant W, Kauf TL, et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006;148:353-358
3. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562
4. Heathcote EJ. Antiviral therapy: chronic hepatitis C. J Viral Hepat 2007;14 (Suppl 1):82-88
5. Gonzalez-Peralta RP, Kelly DA, Haber B, et al. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 2005;42: 1010-1018
6. Pearlman BL. Hepatitis C treatment update. Am J Med 2004;117:344-352
7. Jacobson KR, Murray K, Zellos A, et al. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2002;34:52-58
8. Zegans ME, Anninger W, Chapman C, et al. Ocular manifestations of hepatitis C virus infection. Curr Opin Ophthalmol 2002;13:423-427
9. Ikebe T, Nakatsuka K, Goto M, et al. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn (Ganka- Kiyo) 1990;41:2291-2296
10. Abe T, Nakajima A, Satoh N, et al. Clinical characteristics of hepatitis C virus-associated retinopathy. Jpn J Ophthalmol 1995;39:411-419
11. Manesis EK, Moschos M, Brouzas D, et al. Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis. Hepatology 1998;27:1421-1427
12. Matsuo T, Takabatake R. Multiple sclerosis-like disease secondary to alpha interferon. Ocul Immunol Inflamm 2002;10:299-304.
13. Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006;12: 3756-3759
14. Schulman JA, Liang C, Kooragayala LM, et al. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003;110:437-442
15. Sene D, Touitou V, Bodaghi B, et al. Intraocular complications of IFNalpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 2007;13:3137-3140
16. Vardizer Y, Linhart Y, Loewenstein A, et al. Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy. J Neuroophthalmol 2003;23:256-259
17. Zandieh I, Adenwalla M, Cheong-Lee C, et al. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C. World J Gastroenterol 2006;12:4908-4910
18. Nicolo M, Artioli S, La Mattina GC, et al. Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. Eur J Ophthalmol 2005;15:811-814
19. Kuga K, Hasumura S, Nagamori S, et al. Intraocular hemorrhage developing during interferon therapy. Intern Med 1996;35:15-18
20. d'Alteroche L, Majzoub S, Lecuyer AI, et al. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis. J Hepatol 2006;44:56-61.
21. Yan KK, Dinihan I, Freiman J, et al. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C. Intern Med J 2008;38:207-210
22. Kiuchi K, Kitagawa C, Miyashiro M. Serious loss of vision in bilateral anterior ischemic optic neuropathy caused by interferon. Nippon Ganka Gakkai Zasshi 2009;113:16-23.
23. Goncalves LL, Farias AQ, Goncalves PL, et al. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. World J Gastroenterol 2006;12: 4602-4603